NAGIOS: RODERIC FUNCIONANDO
Efficacy and safety of two artificial saliva-based polymers containing 0.1% pilocarpine for treatment of xerostomia : a randomized clinical pilot trial
Repositori DSpace/Manakin
- Inici
- Investigació
- Revistes
- Journal of Clinical and Experimental Dentistry
- Journal of Clinical and Experimental Dentistry. 2021. Vol. 13, no. 10
- Visualitza element
IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/
Efficacy and safety of two artificial saliva-based polymers containing 0.1% pilocarpine for treatment of xerostomia : a randomized clinical pilot trial
Mostra el registre complet de l'element
|
Visualització
|
| Sarideechaigul, W.; Priprem, A.; Limsitthichaikoon, S.; Phothipakdee, P.; Chaijit, R.; Jorns, Teekayu P.; Lungruammit, N.; Chaiya, K. | |||
| Aquest document és un/a article, creat/da en: 2021 | |||
|
Este documento está disponible también en : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501859/ |
|||
|
|||
| Topical agents are the mainstay in the treatment of xerostomia, a common complaint most frequently associated with salivary dysfunction. This study aimed to compared the efficacy and safety for xerostomia treatment of 2 artificial saliva preparations containing 0.1% pilocarpine, and, either sodium carboxymethylcellulose (SCMC), or, sodium polyacrylate (SPA). | |||
| Veure al catàleg Trobes | |||